​

Coeptis Therapeutics Ownership | Who Owns Coeptis Therapeutics?

OverviewRevenueFinancialsChart

Coeptis Therapeutics Ownership Summary

Coeptis Therapeutics is owned by 0.01% institutional investors, 18.51% insiders, and 81.48% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.78% of its assets in Coeptis Therapeutics shares.

COEP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCoeptis Therapeutics0.01%18.51%81.48%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-92.86%2,250-99.87%-0.03%--100.00%1-66.67%
Sep 30, 202414-17.65%1,706,1411.72%423.34%4-33.33%3-
Jun 30, 202417-15.00%1,677,279-64.64%42.87%6-33.33%350.00%
Mar 31, 2024205.26%4,744,0070.24%128.15%9-35.71%2-
Dec 31, 20231935.71%4,732,85043.81%1216.82%14100.00%2100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr27.53K0.78%-
Fidelity Extended Market Index11.71K0.33%-31.00
Fidelity Series Total Market Index3.07K0.09%-
Spartan Extended Market Index Pool F2.74K0.08%-
Northern Trust Extended Eq Market Idx2.53K0.07%-
NT Ext Equity Mkt Idx Fd - L2.53K0.07%-
Spartan Total Market Index Pool G1.32K0.04%-
Fidelity Total Market Index1.15K0.03%-
NT Ext Eq Mkt Indx Fd DC Lending Tier 5714.000.02%106.00
Fidelity Nasdaq Composite Index292.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 10, 2024Cogley Brian Chief Financial OfficerBuy$3.35K
Jan 12, 2024DeSilva Tara-Buy$260.96
Jan 12, 2024DeSilva Tara-Buy$1.04K
Jan 05, 2024Yerace Daniel Alexander VP of OperationsBuy$7.49K
Jan 05, 2024Salkind Gene-Buy$8.00K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q19-
2023 Q4--
2023 Q34-
2023 Q1--

COEP Ownership FAQ

Who Owns Coeptis Therapeutics?

Coeptis Therapeutics shareholders are primarily institutional investors at 0.01%, followed by 18.51% insiders and 81.48% retail investors. The average institutional ownership in Coeptis Therapeutics's industry, Biotech Stocks , is 64.05%, which Coeptis Therapeutics falls below.

Does Blackrock own Coeptis Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Coeptis Therapeutics.

Who is the top mutual fund holder of Coeptis Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Coeptis Therapeutics shares, with 0.78% of its total shares outstanding invested in 27.53K Coeptis Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools